TrialBMC medicine2023

Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.

Mingtong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.